Skip to content

ORKA · Oruka Therapeutics, Inc.

Healthcare · −2.6% on Oct 16

☆ Add to watchlist

Updated Oct 17 · 6 feeds behind: Insider filings, 2 days, and 5 more · Every feed →

On this page

The market view

Price chart

The interactive ORKA chart (by TradingView) loads here.

Our take

4 rules fired on ORKA

In short: none of these rules has solid or some evidence yet, so they show no clear lean on ORKA.

How each did in past tests, against similar stocks over 3 months. Past results don't predict future ones.

All 4 rules
The 0–100 score for ORKA, and which of these rules are open on it right now
Members see one number for how strongly these rules agree on ORKA, and the day each rule fired. Better-tested rules count more, and so do different kinds of filings that point the same way.
See pricing →
Already a member? Sign in

Compare with this company’s history

Is disclosure activity unusual?

See how many different insiders or members of Congress reported purchases or sales of ORKA. Each bar covers 28 days, by disclosure date. Several trades by one person count once in each group and period.

Latest period: Sep 21, 2026–Oct 18, 2026 · UTC dates · today is excluded

Insider sales

Short history

Only 3 earlier periods are on file to compare with. We need at least 6 full periods before calling a count unusual.

Latest 28 days
4
Earlier median
5
Earlier range
3–8
Distinct filers per 28 daysScale: 0–8
Oct 20, 2025Oct 18, 2026
Earlier periodsLatest 28 daysEarlier median 5Limited or missing history

Who appears in the latest period?

Up to three filers; one example disclosure each.

Inspect this period’s filings

The history behind this view

First stored company disclosure: Jun 12, 2026. Newest disclosure across this feed: Oct 16, 2026.

Earlier periods in the comparison: 3. Outlined periods are missing data, so they are left out of the comparison. The chart scale changes with the category.

Exact counts, dates and filings for all four categories
Insider purchases · Short history

Only 3 earlier periods are on file to compare with. We need at least 6 full periods before calling a count unusual. Earlier median: 0; range: 0–0.

Insider purchases: distinct filers in stored disclosures
Period and filingsFilersHistory
Oct 20, 2025–Nov 16, 2025—Unavailable
Nov 17, 2025–Dec 14, 2025—Unavailable
Dec 15, 2025–Jan 11, 2026—Unavailable
Jan 12, 2026–Feb 8, 2026—Unavailable
Feb 9, 2026–Mar 8, 2026—Unavailable
Mar 9, 2026–Apr 5, 2026—Unavailable
Apr 6, 2026–May 3, 2026—Unavailable
May 4, 2026–May 31, 2026—Unavailable
Jun 1, 2026–Jun 28, 20260Partial; excluded
Jun 29, 2026–Jul 26, 20260Within stored history
Jul 27, 2026–Aug 23, 20260Within stored history
Aug 24, 2026–Sep 20, 20260Within stored history
Sep 21, 2026–Oct 18, 2026Latest period0Within stored history
Insider sales · Short history

Only 3 earlier periods are on file to compare with. We need at least 6 full periods before calling a count unusual. Earlier median: 5; range: 3–8.

Insider sales: distinct filers in stored disclosures
Period and filingsFilersHistory
Oct 20, 2025–Nov 16, 2025—Unavailable
Nov 17, 2025–Dec 14, 2025—Unavailable
Dec 15, 2025–Jan 11, 2026—Unavailable
Jan 12, 2026–Feb 8, 2026—Unavailable
Feb 9, 2026–Mar 8, 2026—Unavailable
Mar 9, 2026–Apr 5, 2026—Unavailable
Apr 6, 2026–May 3, 2026—Unavailable
May 4, 2026–May 31, 2026—Unavailable
Jun 1, 2026–Jun 28, 20266Partial; excluded
Jun 29, 2026–Jul 26, 20268Within stored history
Jul 27, 2026–Aug 23, 20263Within stored history
Aug 24, 2026–Sep 20, 20265Within stored history
Sep 21, 2026–Oct 18, 2026Latest period4Within stored history
Congress purchases · History unavailable

No completed-period disclosures for this company are available in this source. Missing history is not zero activity. Earlier median: —; range: unavailable.

Congress purchases: distinct filers in stored disclosures
Period and filingsFilersHistory
Oct 20, 2025–Nov 16, 2025—Unavailable
Nov 17, 2025–Dec 14, 2025—Unavailable
Dec 15, 2025–Jan 11, 2026—Unavailable
Jan 12, 2026–Feb 8, 2026—Unavailable
Feb 9, 2026–Mar 8, 2026—Unavailable
Mar 9, 2026–Apr 5, 2026—Unavailable
Apr 6, 2026–May 3, 2026—Unavailable
May 4, 2026–May 31, 2026—Unavailable
Jun 1, 2026–Jun 28, 2026—Unavailable
Jun 29, 2026–Jul 26, 2026—Unavailable
Jul 27, 2026–Aug 23, 2026—Unavailable
Aug 24, 2026–Sep 20, 2026—Unavailable
Sep 21, 2026–Oct 18, 2026Latest period—Unavailable
Congress sales · History unavailable

No completed-period disclosures for this company are available in this source. Missing history is not zero activity. Earlier median: —; range: unavailable.

Congress sales: distinct filers in stored disclosures
Period and filingsFilersHistory
Oct 20, 2025–Nov 16, 2025—Unavailable
Nov 17, 2025–Dec 14, 2025—Unavailable
Dec 15, 2025–Jan 11, 2026—Unavailable
Jan 12, 2026–Feb 8, 2026—Unavailable
Feb 9, 2026–Mar 8, 2026—Unavailable
Mar 9, 2026–Apr 5, 2026—Unavailable
Apr 6, 2026–May 3, 2026—Unavailable
May 4, 2026–May 31, 2026—Unavailable
Jun 1, 2026–Jun 28, 2026—Unavailable
Jun 29, 2026–Jul 26, 2026—Unavailable
Jul 27, 2026–Aug 23, 2026—Unavailable
Aug 24, 2026–Sep 20, 2026—Unavailable
Sep 21, 2026–Oct 18, 2026Latest period—Unavailable
How to read this comparison

The median is the middle count in up to 12 earlier, non-overlapping 28-day periods; the range runs from the smallest to the largest count. The latest period is excluded from both. A comparison needs at least 6 earlier periods, including 3 with activity. The feed’s latest disclosure must be within 7 days of the current period’s end. This freshness check does not verify complete collection.

Insiders include individuals and reporting entities; only purchase and sale codes enter this view. Congress counts reporting members, including their disclosed family transactions. The same filer can appear in purchases and sales, so these categories should not be added into a net count.

These are stored disclosures, not a complete measure of trading. Reporting delays and collection gaps can change the comparison. More activity does not identify a motive or predict a stock’s return.

Company timeline

What has been happening?

May 1, 2026–Oct 16, 2026. Select a month in a category to inspect its records.

Company filings

Insiders

Owners & lobbying

Insiders · Oct 2026

  1. Disclosed
    Joana Goncalves · Sale

    Transaction dated Oct 15, 2026

  2. Disclosed
    Joana Goncalves · Sale

    Transaction dated Oct 15, 2026

  3. Disclosed
    Joana Goncalves · Sale

    Transaction dated Oct 15, 2026

  4. Disclosed
    Joana Goncalves · Sale

    Transaction dated Oct 15, 2026

  5. Disclosed
    Joana Goncalves · Sale

    Transaction dated Oct 15, 2026

  6. Filed
  7. Disclosed
    Arjun Agarwal · Sale

    Transaction dated Oct 12, 2026

  8. Disclosed
    Arjun Agarwal · Sale

    Transaction dated Oct 12, 2026

  9. Disclosed
    Arjun Agarwal · Sale

    Transaction dated Oct 12, 2026

  10. Disclosed
    Arjun Agarwal · Sale

    Transaction dated Oct 12, 2026

  11. Filed
  12. Disclosed
    Lawrence Otto Klein · Sale

    Transaction dated Oct 1, 2026

  13. Disclosed
    Lawrence Otto Klein · Sale

    Transaction dated Oct 1, 2026

  14. Disclosed
    Lawrence Otto Klein · Sale

    Transaction dated Oct 1, 2026

  15. Filed
All 40 records in this snapshot
  1. Disclosed
    Joana Goncalves · Sale

    Transaction dated Oct 15, 2026

  2. Disclosed
    Joana Goncalves · Sale

    Transaction dated Oct 15, 2026

  3. Disclosed
    Joana Goncalves · Sale

    Transaction dated Oct 15, 2026

  4. Disclosed
    Joana Goncalves · Sale

    Transaction dated Oct 15, 2026

  5. Disclosed
    Joana Goncalves · Sale

    Transaction dated Oct 15, 2026

  6. Filed
  7. Disclosed
    Arjun Agarwal · Sale

    Transaction dated Oct 12, 2026

  8. Disclosed
    Arjun Agarwal · Sale

    Transaction dated Oct 12, 2026

  9. Disclosed
    Arjun Agarwal · Sale

    Transaction dated Oct 12, 2026

  10. Disclosed
    Arjun Agarwal · Sale

    Transaction dated Oct 12, 2026

  11. Filed
  12. Disclosed
    Lawrence Otto Klein · Sale

    Transaction dated Oct 1, 2026

  13. Disclosed
    Lawrence Otto Klein · Sale

    Transaction dated Oct 1, 2026

  14. Disclosed
    Lawrence Otto Klein · Sale

    Transaction dated Oct 1, 2026

  15. Filed
  16. Disclosed
    Arjun Agarwal · Sale

    Transaction dated Sep 21, 2026

  17. Filed
  18. Disclosed
    Paul T Quinlan · Sale

    Transaction dated Sep 21, 2026

  19. Disclosed
    Paul T Quinlan · Sale

    Transaction dated Sep 21, 2026

  20. Disclosed
    Paul T Quinlan · Sale

    Transaction dated Sep 21, 2026

  21. Disclosed
    Paul T Quinlan · Sale

    Transaction dated Sep 21, 2026

  22. Disclosed
    Arjun Agarwal · Sale

    Transaction dated Sep 11, 2026

  23. Disclosed
    Arjun Agarwal · Sale

    Transaction dated Sep 11, 2026

  24. Disclosed
    Arjun Agarwal · Sale

    Transaction dated Sep 11, 2026

  25. Disclosed
    Joana Goncalves · Sale

    Transaction dated Sep 15, 2026

  26. Disclosed
    Joana Goncalves · Sale

    Transaction dated Sep 15, 2026

  27. Disclosed
    Joana Goncalves · Sale

    Transaction dated Sep 15, 2026

  28. Disclosed
    Lawrence Otto Klein · Sale

    Transaction dated Sep 15, 2026

  29. Disclosed
    Paul T Quinlan · Sale

    Transaction dated Sep 15, 2026

  30. Filed
  31. Filed
  32. Filed
  33. Filed
  34. Filed
  35. Filed
  36. Filed
  37. Filed
  38. Filed
  39. Record date
  40. Filed

Month counts include every record on file. The lists show the newest records on this page. A dash means none on file that month. Trades use disclosure dates; contract dates follow the source record. Nearby events do not establish the cause of a price move.

Who's buying and selling · last 90 days

Congress

No Congress trades on ORKA disclosed in the last 90 days.

See every Congress trade on ORKA →

Company insiders

0 buys · 15 sells (50 filed lots) · $21.3M sold

  1. ▼ SELLJoana Goncalves Chief Medical OfficerORKA Oruka Therapeutics, Inc.$53.7Kdisclosed Oct 15 · filed the same day
  2. ▼ SELLJoana Goncalves Chief Medical OfficerORKA Oruka Therapeutics, Inc.$106Kdisclosed Oct 15 · filed the same day
  3. ▼ SELLJoana Goncalves Chief Medical OfficerORKA Oruka Therapeutics, Inc.$211Kdisclosed Oct 15 · filed the same day
  4. ▼ SELLJoana Goncalves Chief Medical OfficerORKA Oruka Therapeutics, Inc.$138Kdisclosed Oct 15 · filed the same day
  5. ▼ SELLJoana Goncalves Chief Medical OfficerORKA Oruka Therapeutics, Inc.$15.5Kdisclosed Oct 15 · filed the same day
  6. ▼ SELLArjun Agarwal Senior Vice President, FinanceORKA Oruka Therapeutics, Inc.$16.6Kdisclosed Oct 13 · filed 1 day after the trade
  7. ▼ SELLArjun Agarwal Senior Vice President, FinanceORKA Oruka Therapeutics, Inc.$160Kdisclosed Oct 13 · filed 1 day after the trade
  8. ▼ SELLArjun Agarwal Senior Vice President, FinanceORKA Oruka Therapeutics, Inc.$170Kdisclosed Oct 13 · filed 1 day after the trade
  9. ▼ SELLArjun Agarwal Senior Vice President, FinanceORKA Oruka Therapeutics, Inc.$459Kdisclosed Oct 13 · filed 1 day after the trade
  10. ▼ SELLLawrence Otto Klein Chief Executive OfficerORKA Oruka Therapeutics, Inc.$719Kdisclosed Oct 2 · filed 1 day after the trade
See every insider trade on ORKA →

Big holders (Schedule 13D / 13G): 2 filings in the last 90 days · newest: Rtw Investments, LP (13G), Aug 14, 2026 ↗

Filings & events

Company filings (8-K) 62

Events the company must report to the SEC within days — results, deals, departures, restatements.

What it files 8-Ks about

  • Directors or officers joined, left or got new pay · item 5.029
  • Quarterly or yearly results · item 2.027
  • Other events · item 8.016
  • Signed a major agreement · item 1.015
  • Shareholder vote results · item 5.073
  • Shared information with investors · item 7.013

Filing red flags 45

Warning signs in the company's own SEC filings — going-concern doubts, control weaknesses, staff comment letters, late filings, restatements, Wells notices, clinical holds, dividend cuts.

Planned insider sales (Form 144) 17

Notices insiders file before they sell certain shares, such as ones they got straight from the company.

7 in the last 90 days · 17 notices on file

The notices on file don't give the sale's size; each sale shows up under company insiders once it is reported.

5% owners (13D / 13G) 12

Investors who reported owning 5% or more — 13D for owners who may push for changes, 13G for owners who just hold.

Push for changes, or just hold?

  • 13D, may push for changes: 4 filings
  • 13G, just holds: 8 filings

Filed most: Fairmount Funds Management LLC (4) · Rtw Investments, LP (2) · BlackRock, Inc. (2) · Capital World Investors (1)

Biggest named funds (13F)

The largest ORKA holdings among the well-known funds whose quarterly 13F filings we read — opens here.

Every disclosed trade on ORKA

  1. ▼ SELLJoana Goncalves Chief Medical OfficerORKA Oruka Therapeutics, Inc.$53.7Kdisclosed Oct 15 · filed the same day
  2. ▼ SELLJoana Goncalves Chief Medical OfficerORKA Oruka Therapeutics, Inc.$106Kdisclosed Oct 15 · filed the same day
  3. ▼ SELLJoana Goncalves Chief Medical OfficerORKA Oruka Therapeutics, Inc.$211Kdisclosed Oct 15 · filed the same day
  4. ▼ SELLJoana Goncalves Chief Medical OfficerORKA Oruka Therapeutics, Inc.$138Kdisclosed Oct 15 · filed the same day
  5. ▼ SELLJoana Goncalves Chief Medical OfficerORKA Oruka Therapeutics, Inc.$15.5Kdisclosed Oct 15 · filed the same day
  6. ▼ SELLArjun Agarwal Senior Vice President, FinanceORKA Oruka Therapeutics, Inc.$16.6Kdisclosed Oct 13 · filed 1 day after the trade
  7. ▼ SELLArjun Agarwal Senior Vice President, FinanceORKA Oruka Therapeutics, Inc.$160Kdisclosed Oct 13 · filed 1 day after the trade
  8. ▼ SELLArjun Agarwal Senior Vice President, FinanceORKA Oruka Therapeutics, Inc.$170Kdisclosed Oct 13 · filed 1 day after the trade
  9. ▼ SELLArjun Agarwal Senior Vice President, FinanceORKA Oruka Therapeutics, Inc.$459Kdisclosed Oct 13 · filed 1 day after the trade
  10. ▼ SELLLawrence Otto Klein Chief Executive OfficerORKA Oruka Therapeutics, Inc.$719Kdisclosed Oct 2 · filed 1 day after the trade
  11. ▼ SELLLawrence Otto Klein Chief Executive OfficerORKA Oruka Therapeutics, Inc.$1.4Mdisclosed Oct 2 · filed 1 day after the trade
  12. ▼ SELLLawrence Otto Klein Chief Executive OfficerORKA Oruka Therapeutics, Inc.$17Kdisclosed Oct 2 · filed 1 day after the trade
  13. ▼ SELLPaul T Quinlan General CounselORKA Oruka Therapeutics, Inc.$254Kdisclosed Sep 21 · filed the same day
  14. ▼ SELLPaul T Quinlan General CounselORKA Oruka Therapeutics, Inc.$268Kdisclosed Sep 21 · filed the same day
  15. ▼ SELLPaul T Quinlan General CounselORKA Oruka Therapeutics, Inc.$358Kdisclosed Sep 21 · filed the same day
  16. ▼ SELLArjun Agarwal Senior Vice President, FinanceORKA Oruka Therapeutics, Inc.$51Kdisclosed Sep 21 · filed the same day
  17. ▼ SELLPaul T Quinlan General CounselORKA Oruka Therapeutics, Inc.$56.8Kdisclosed Sep 21 · filed the same day
  18. ▼ SELLArjun Agarwal Senior Vice President, FinanceORKA Oruka Therapeutics, Inc.$273Kdisclosed Sep 15 · filed 4 days after the trade
  19. ▼ SELLJoana Goncalves Chief Medical OfficerORKA Oruka Therapeutics, Inc.$290Kdisclosed Sep 15 · filed the same day
  20. ▼ SELLArjun Agarwal Senior Vice President, FinanceORKA Oruka Therapeutics, Inc.$206Kdisclosed Sep 15 · filed 4 days after the trade
  21. ▼ SELLLawrence Otto Klein Chief Executive OfficerORKA Oruka Therapeutics, Inc.$235Kdisclosed Sep 15 · filed the same day
  22. ▼ SELLArjun Agarwal Senior Vice President, FinanceORKA Oruka Therapeutics, Inc.$374Kdisclosed Sep 15 · filed 4 days after the trade
  23. ▼ SELLJoana Goncalves Chief Medical OfficerORKA Oruka Therapeutics, Inc.$9.4Kdisclosed Sep 15 · filed the same day
  24. ▼ SELLJoana Goncalves Chief Medical OfficerORKA Oruka Therapeutics, Inc.$127Kdisclosed Sep 15 · filed the same day
  25. ▼ SELLPaul T Quinlan General CounselORKA Oruka Therapeutics, Inc.$99.4Kdisclosed Sep 15 · filed the same day
See all 81 trades on ORKA →
People & votes

Which members of Congress traded ORKA, sponsored bills that touch it and voted on them — opens here.